Medicare Advantage(MA)与全髋或全膝关节置换术后假体周围感染抗生素骨水泥间隔物置入术后90天死亡率升高相关
该研究利用2015至2021年全国代表性数据库,纳入40346例因髋或膝关节假体周围感染行第一阶段抗生素骨水泥间隔物置入的成人患者,比较传统Medicare(TM)与Medicare Advantage(MA)覆盖患者的90天死亡率。MA组90天死亡率1.4%高于TM组1.0%(P=0.004),多变量校正后MA组死亡风险仍显著升高(校正OR=1.42,95%CI 1.11-1.81,P=0.005)。作者认为需进一步研究以理解该差异的原因。
要点
- MA覆盖患者第一阶段抗生素骨水泥间隔物置入术后90天死亡率1.4%,高于TM覆盖患者的1.0%(P=0.004)。
- 多变量校正后,MA组90天死亡风险仍显著高于TM组(校正OR=1.42,95%CI 1.11-1.81,P=0.005)。
- 作者结论认为需进一步研究以更好理解该发现的潜在原因。
核心结论
- 在纳入多变量分析可获得的混杂因素后,MA计划参保患者术后90天内死亡的可能性比TM覆盖患者高40%以上。
- 作者指出需进一步研究以更好理解该发现的潜在原因。
研究设计与样本
- 研究利用2015至2021年全国代表性数据库,纳入因髋或膝关节假体周围感染行第一阶段抗生素骨水泥间隔物置入的成人患者。
- 采用国际疾病分类第10版和现行操作术语代码及抗生素住院费用识别行第一阶段置换关节成形术的假体周围感染患者。
- 患者分为TM组和MA组,主要结局为90天死亡率的比值比,并采用多变量逻辑回归校正人口学、合并症和医院特征等可能的混杂因素。
主要发现
- 40346例因假体周围感染行第一阶段间隔物置入的患者中,16637例(41.2%)为TM覆盖,9218例(22.8%)为MA覆盖。
- MA组术后90天内死亡率为1.4%,TM组为1.0%(P=0.004)。
- 多变量逻辑回归显示MA组校正后死亡比值比显著高于TM组(校正OR=1.42,95%CI 1.11-1.81,P=0.005)。
局限性
- 作者指出需进一步研究以更好理解该发现的潜在原因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Privatized Medicare Advantage (MA) plans are an alternative to traditional Medicare (TM). We sought to identify differences in 90-day postoperative mortality and nonfatal adverse events between TM and MA patients undergoing stage 1 antibiotic spacer placement for periprosthetic joint infection (PJI) of the hip or knee. METHODS: A nationally representative database was queried from 2015 to 2021 for adult patients undergoing stage 1 antibiotic spacer placement for PJI. Using the International Classification of Disease, 10th Revision, and Current Procedural Terminology codes, as well as hospital charges for antibiotics, patients undergoing stage 1 exchange arthroplasty for PJI were identified. Patients were then grouped into TM and MA cohorts. The primary outcome was the odds of 90-day mortality. Multivariable logistic regressions were conducted to address possible confounding demographic, comorbidity, and hospital characteristics. RESULTS: Of the 40,346 patients undergoing stage 1 spacer placement for PJI, 16,637 (41.2%) had TM coverage and 9,218 (22.8%) had MA coverage. Mortality within 90 days of surgery was higher in the MA cohort (1.4% versus 1.0%, P = 0.004). Multivariable logistic regression demonstrated significantly higher adjusted odds of mortality (adjusted odds ratio = 1.42, 95% confidence interval = 1.11 to 1.81, P = 0.005) in MA patients compared to TM. CONCLUSIONS: Even after accounting for available confounders with our multivariable analyses, patients enrolled in an MA plan were more than 40% more likely to die within 90 days of surgery compared to patients who have TM coverage. Further study is necessary to better understand the underlying cause of this finding.
引用
- Heckmann ND, Wier J, Liu KC, et al. Medicare Advantage Is Associated With Higher Mortality After Antibiotic Spacer Placement for Periprosthetic Joint Infection. J Arthroplasty. 2024. PMID: 39424239. doi:10.1016/j.arth.2024.10.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。